Cellectis (CLLS) Stock Chart & Stock Price History $1.52 +0.08 (+5.17%) As of 03:49 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectis Stock Price Performance The Cellectis (CLLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 18.45%, with a year-to-date return of -15.28%. In the past month, the stock has increased 5.39%, reflecting recent market activity. As of the latest close, Cellectis traded at $1.45 with a market cap of $80.59 million and volume of 50,843 shares. Five years ago, the stock traded at $17.94, representing a 91.50% decrease over that period. At the time, it had a market cap of $770.62 million and a volume of 102,200 shares. Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.67%1 Month Performance+5.39%3 Month Performance+20.08%Year-To-Date Performance-15.28%1 Year Performance-18.45%5 Year Performance-91.50% CLLS Stock Chart for Monday, June, 30, 2025 CLLS Chart by TradingView Cellectis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$1.45$1.53+5.17%$1.60$1.4255,219 shs$84.77 million06/27/2025$1.47$1.45-1.36%$1.51$1.4150,843 shs$80.59 million06/26/2025$1.50$1.47-2.00%$1.51$1.4532,320 shs$81.70 million06/25/2025$1.47$1.50+2.04%$1.51$1.4042,342 shs$83.37 million06/24/2025$1.44$1.47+2.08%$1.48$1.4132,669 shs$81.70 million06/23/2025$1.47$1.44-2.04%$1.49$1.3559,952 shs$80.04 million06/20/2025$1.38$1.47+6.52%$1.47$1.3677,868 shs$81.70 million06/19/2025$1.38$1.38$1.42$1.3536,065 shs$76.70 million06/18/2025$1.37$1.38+0.73%$1.42$1.3536,065 shs$76.70 million06/17/2025$1.39$1.37-1.08%$1.42$1.3524,628 shs$76.15 million Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$1.33$1.39+4.14%$1.42$1.3549,797 shs$76.98 million06/13/2025$1.37$1.33-2.69%$1.43$1.3363,678 shs$73.93 million06/12/2025$1.41$1.37-2.72%$1.44$1.3652,598 shs$75.97 million06/11/2025$1.41$1.41-0.35%$1.46$1.4022,866 shs$78.10 million06/10/2025$1.43$1.41-1.05%$1.42$1.4065,944 shs$78.37 million06/09/2025$1.41$1.43+1.06%$1.46$1.3970,158 shs$79.21 million06/06/2025$1.45$1.41-2.42%$1.49$1.3770,273 shs$78.37 million06/05/2025$1.43$1.45+1.05%$1.48$1.42110,371 shs$80.32 million06/04/2025$1.46$1.43-2.05%$1.47$1.4247,733 shs$79.49 million06/03/2025$1.49$1.46-2.01%$1.51$1.4515,731 shs$81.15 million06/02/2025$1.45$1.49+2.97%$1.55$1.4741,664 shs$82.82 million05/30/2025$1.44$1.45+0.49%$1.47$1.41103,936 shs$80.43 million05/29/2025$1.41$1.44+2.13%$1.48$1.4169,672 shs$80.04 million Related Companies IVA Stock Price Chart ATXS Stock Price Chart GOSS Stock Price Chart AURA Stock Price Chart AARD Stock Price Chart OLMA Stock Price Chart AVTE Stock Price Chart OCGN Stock Price Chart GLUE Stock Price Chart AVIR Stock Price Chart Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLLS) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | SponsoredHow high will gold surge? Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and de...Weiss Ratings | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLLS Stock Alerts